On 2025-05-14, Acrivon Therapeutics, Inc. (ACRV) announced earnings per share of $-0.51 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-0.57.
The next expected annoucement date for quarterly earnings is 2025-08-12, with an average estimated earnings per share of $-0.57 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-14 | 2025-03-31 | $-0.57 | $-0.51 |
| 2025-03-27 | 2024-12-31 | $-0.69 | $-0.60 |
| 2024-11-13 | 2024-09-30 | $-0.56 | $-0.59 |
| 2024-08-13 | 2024-06-30 | $-0.59 | $-0.52 |
| 2024-05-14 | 2024-03-31 | $-0.89 | $-0.73 |
| 2024-03-28 | 2023-12-31 | $-0.72 | $-0.86 |
| 2023-11-09 | 2023-09-30 | $-0.72 | $-0.66 |
| 2023-08-11 | 2023-06-30 | $-0.68 | $-0.63 |
| 2023-05-09 | 2023-03-31 | $-0.64 | $-0.58 |
| 2023-03-28 | 2022-12-31 | $-1.10 | $-0.80 |
| 2022-12-15 | 2022-09-30 | $-2.44 | $-5.17 |